Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0002871 (anemia)
 52,094 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The average hemoglobin (Hb) and hematocrit (Hc) values determined in our own investigations with 491 rearing calves in the first five months of their lives were compared with the nationally and internationally published data of the dependence of these hematologic values on the age or rearing resp. milk fattening calves. The main influencing factors on the ageing development were the initial level of Hb and Hc, the length of the milk feeding period, the time of the beginning of feed supplementing, the development of dry matter consumption resp. the supply with milk, the iron content of the milk exchanger and the live weight increase achieved under the respective nutritional conditions. This dependence on the development proves that anaemia occurring with rearing calves in the first few weeks of their lives is mainly caused by iron deficiency. From the similarity of the average Hb resp. Hc values one can derive the conclusion that the considerable anaemia frequencies observed in one's investigations are not a phenomenon specific of one farm or of time but represent a general problem of the rearing of calves without iron substitution.
 ...
PMID:[Reference values of hemoglobin content, hematocrit and mean concentration of corpuscular hemoglobin of calves reared without iron supplementation. 3. Comparison of the observed age dependency with literature values]. 707 97

Erythropoietin (EPO) has revolutionized the treatment of anemia in renal failure patients, both in the pre- and postdialysis phase. Not only does the treatment improve well being, but also it positively influences cardiac function and permits cardiac hypertrophy to regress. EPO can lead to an increase in blood pressure; the mechanisms of this effect are not entirely clear. By optimizing dialysis treatment, paying close attention to volume regulation, giving EPO subcutaneously and in a fashion to increase hematocrit gradually, the occurrence of blood pressure increases can be minimized. Hypertension has not proved to be a serious general problem in the EPO treated patient.
 ...
PMID:Erythropoietin and arterial hypertension. 1074 8